Abstract
Background medication adherence is one determining factor of treatment success. Poor medication adherence mitigates optimum clinical benefits and increases total health care costs. Current evidence suggests that for population-based adherence interventions to be effective, a multidisciplinary, multifactorial approach that can be tailored for each individual should be adopted. In the United States, national organizations such as the National Committee for Quality Assurance and the Centers for Medicare and Medicaid Services include medication adherence as a metric of health care system performance Aim of the Commentary This article provides an overview of efforts at Kaiser Permanente Colorado to impact medication adherence-related metrics. Described interventions are supported by electronic data gathering processes with an emphasis on the role of pharmacists.
This is a preview of subscription content, log in via an institution to check access.
References
World Health Organization [Internet]. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; c 2003 [cited 2013 May 22]. Available from: www.who.int/chronic_conditions/en/adherence_report.pdf.
Cramer J, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–7.
Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657–65.
Crowley MJ, Grubber JM, Olsen MK, Bosworth HB. Factors associated with non-adherence to three hypertension self-management behaviors: preliminary data for a new instrument. J Gen Intern Med. 2012;28(1):99–106.
Yood RA, Mazor KM, Andrade SE, Emani S, Chan W, Kahler KH. Patient decision to initiate therapy for osteoporosis: the influence of knowledge and beliefs. J Gen Intern Med. 2008;23(11):1815–21.
Shrank WH, Choudhry NK, Fischer MA, Avorn J, Powell M, Schneeweiss S, et al. The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med. 2010;153(10):640–4.
Solomon DH, Brookhart MA, Tsao P, Sundaresan D, Andrade SE, Mazor K, et al. Predictors of very low adherence with medications for osteoporosis: towards development of a clinical prediction rule. Osteoporos Int. 2011;22(6):1734–43.
Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med. 2010;40(3):248–57.
Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertens Res. 2008;31(9):1765–71.
McHorney CA. The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin. 2009;25(1):215–38.
Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between non-adherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61(3):282–8.
Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.
Raebel MA, Schmittdiel J, Karter AJ, Konieczny JF, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Med Care. 2013;51(8 Suppl 3):S11–21.
PQA Pharmacy Quality Alliance [Internet]. Virginia: Pharmacy Quality Alliance; [cited 2013 May 22]. Available from: http://www.pqaalliance.org/.
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock S, Wines RCM, et al. Medication adherence interventions: comparative effectiveness. Closing the quality gap: revisiting the state of the science. Evidence Report No. 208. (Prepared by RTI International–University of North Carolina Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 12-E010-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2012. www.effectivehealthcare.ahrq.gov/reports/final.cfm.
Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009;2(5):451–7.
Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48(3):196–202.
Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, et al. Characteristics of patients with primary nonadherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012;27(1):57–64.
Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.
Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–24.
Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.
Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care. 2005;43(6):517–20.
Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, et al. Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program. Diab Care. 2006;29(9):1997–2002.
Wu JR, Moser DK, DeJong MJ, Rayens MK, Chung ML, Riegel B, et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009;157(2):285–91.
McGinnis BD, Olson KL, Delate TMA, Stolcpart RS. Statin adherence and mortality in patients enrolled in a secondary prevention program. Am J Manag Care. 2009;15(10):689–95.
Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, et al. Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Arch Intern Med. 2008;168(3):271–6.
McCombs JS, Nichol MB, Newman CM, Sclar DA. The costs of interrupting antihypertensive drug therapy in a Medicaid population. Med Care. 1994;32(3):214–26.
Osterburg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.
Cutler DM, Everett W. Thinking outside the pillbox—medication adherence as a priority for health care reform. N Engl J Med. 2010;362(17):1553–5.
Roebuck MC, Liberman JN, Gemmill-Toyama M. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–9.
NCQA [Internet]. [Washington DC]: National Committee for Quality Assurance; [cited 2013 June 6]. Available from: http://www.ncqa.org/HEDISQualityMeasurement.aspx.
Centers for Medicare and Medicaid Services [Internet]. Baltimore: Centers for Medicare and Medicaid Services; [cited 2013 May 22]. Available from: http://www.cms.gov/.
Helling DK, Nelson K, Ramirez JE, Humphries TL. Kaiser Permanente Colorado Region Pharmacy Department: innovative leader in pharmacy practice. J Am Pharm Assoc. 2006;46(1):67–76.
Steiner JF. Rethinking adherence. Ann Intern Med. 2012;157(8):580–5.
Touchette DR, Shapiro NL. Medication compliance, adherence, and persistence: current status of behavioral and education interventions to improve outcomes. J Manag Care Pharm. 2008;14(6):S2–10.
Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;2:CD004804.
Schedlbauer A, Davies P, Fahey T. Intervention to improve patients’ drug-taking behavior to lipid lowering drugs. Cochrane Database Syst Rev. 2010;3:004371.
Taitel M, Jiang J, Rudkin K, Ewing S, Duncan I. The impact of pharmacist face-to-face counseling to improve medication adherence among patients initiating statin therapy. Patient Prefer Adherence. 2012;6:323–9.
Vervolet M, Linn AJ, Van Weert JCM, de Bakker DH, Bouvy ML, Van Djk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2011;19(5):696–704.
Granger BB, Bosworth HB. Medication adherence: emerging use of technology. Curr Opin Cardiol. 2011;26(4):279–87.
Oyekan E, Nimalasuriya A, Martin J, Scott R, Dudl RJ, Green K. The B-SMART appropriate medication-use process: a guide for clinicians to help patients—part 1: barriers, solutions, and motivation. Perm J. 2009;13(1):62–9.
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.
Topinková E, Baeyens JP, Michel JP, Lang PO. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging. 2012;29(6):477–94.
Pellegrino AN, Martin MT, Tilton JJ, Touchette DR. Medication therapy management: definitions and outcomes. Drugs. 2009;69(4):393–406.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflicts of interest
All authors are employed by KPCO and declare no other conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McGinnis, B., Kauffman, Y., Olson, K.L. et al. Interventions aimed at improving performance on medication adherence metrics. Int J Clin Pharm 36, 20–25 (2014). https://doi.org/10.1007/s11096-013-9872-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-013-9872-y